Diabetes Dialogues
Welcome to the conversation…. Brought to you by Dexcom, the Diabetes Dialogues podcast explores new perspectives and discussions from expert healthcare practitioners in the field of diabetes. In each episode, we will investigate topics from across the spectrum of diabetes care – tune in to discover dialogues that will educate, inspire, and empower.
This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.
Diabetes Dialogues
S2 - Episode 3: Type 2 Diabetes and Technology
Adam and Prof. Sam Seidu take a deeper look into various real world studies and clinical trials that have been conducted in a T2 diabetes cohort using continuous glucose monitoring technology. Discussing the key findings, that can enhance understanding and care for T2 patients.
With / speaker;
Prof. Sam Seidu Professor in Primary Care Diabetes and Cardio-metabolic Medicine, University of Leicester/ GP
*If your glucose alerts and readings from Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
IMMEDIATE study
Aronson R et al. IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trial. Diabetes Obes Metab. 2023;25(4):1024-1031.
MOBILE study
Aleppo G et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care. 2021;44(12):2729-2737.
MAT-7904
This podcast has been created and fully funded by Dexcom UK & Ireland and intended for healthcare professionals practising in the United Kingdom & Ireland.
Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice.
All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom User Guide . For product-related questions, please refer to the instructions for use. For complete safety information, go to https://www.dexcom.com/en-gb/safety-information . Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. Dexcom Distribution Ltd, www.dexcom.com.
Further CPD accredited education can be found on the Dexcom Education Hub